13F

Stock

Anebulo Pharmaceuticals, Inc.

ANEB · held by 19 managers

Reported value

$91.6M

Holders

19

+0 new · −1 exited

Holders’ est. mark

−$595.7K

Price effect on 3 books still in the name

Largest holder

$84.8M

22NW, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
22NW, LP15.5M$84.8MHeld
Nantahala Capital Management, LLC3.04M$3.07MHeld
MANGROVE PARTNERS IM, LLC2.53M$2.55MHeld
Vanguard435.8K$440.2KHeld
MORGAN STANLEY399.4K$403.4K−$595.1KCut−$595.1K
GEODE CAPITAL MANAGEMENT, LLC160.8K$162.5KHeld
Rangeley Capital, LLC50K$50.5KHeld
Renaissance Technologies25.1K$25.3KHeld
Citadel24.2K$24.5KHeld
BlackRock, Inc.23.8K$24KHeld
NORTHERN TRUST CORP22K$22.2KHeld
Ikarian Capital, LLC17.7K$17.9KHeld
State Street12.8K$12.9KHeld
Tower Research Capital LLC (TRC)3.23K$3.26KHeld
UBS Group AG2.33K$2.36KHeld
JPMORGAN CHASE & CO2.25K$2.28KHeld
BANK OF AMERICA CORP /DE/382$386−$569Cut−$1.84K
FNY Investment Advisers, LLC100$0$0Held
ROYAL BANK OF CANADA30$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.